FK-448 Free base is used as a potent and specific chymotrypsin inhibitor; it moderately inhibits cathepsin G; it decreases blood glucose levels and inhibits insulin degradation by pancreatic enzymes in rats; it also reduces blood glucose and increases plasma immunoreactive insulin (IRI) levels in dogs.